nodes	percent_of_prediction	percent_of_DWPC	metapath
Arformoterol—CYP2C19—Vismodegib—skin cancer	0.177	0.279	CbGbCtD
Arformoterol—CYP2A6—Fluorouracil—skin cancer	0.152	0.239	CbGbCtD
Arformoterol—CYP2C9—Vismodegib—skin cancer	0.147	0.232	CbGbCtD
Arformoterol—CYP2D6—Vemurafenib—skin cancer	0.106	0.168	CbGbCtD
Arformoterol—CYP2C9—Fluorouracil—skin cancer	0.0522	0.0823	CbGbCtD
Arformoterol—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000797	0.00218	CcSEcCtD
Arformoterol—Fatigue—Vemurafenib—skin cancer	0.000796	0.00218	CcSEcCtD
Arformoterol—Neoplasm—Docetaxel—skin cancer	0.000795	0.00217	CcSEcCtD
Arformoterol—Nasopharyngitis—Fluorouracil—skin cancer	0.000791	0.00216	CcSEcCtD
Arformoterol—Constipation—Vemurafenib—skin cancer	0.000789	0.00216	CcSEcCtD
Arformoterol—Oedema—Imiquimod—skin cancer	0.000787	0.00215	CcSEcCtD
Arformoterol—Infection—Imiquimod—skin cancer	0.000782	0.00214	CcSEcCtD
Arformoterol—Nervous system disorder—Imiquimod—skin cancer	0.000772	0.00211	CcSEcCtD
Arformoterol—Upper respiratory tract infection—Temozolomide—skin cancer	0.000771	0.00211	CcSEcCtD
Arformoterol—Tachycardia—Imiquimod—skin cancer	0.000768	0.0021	CcSEcCtD
Arformoterol—Skin disorder—Imiquimod—skin cancer	0.000764	0.00209	CcSEcCtD
Arformoterol—Hyperglycaemia—Temozolomide—skin cancer	0.000748	0.00205	CcSEcCtD
Arformoterol—Angina pectoris—Fluorouracil—skin cancer	0.000744	0.00204	CcSEcCtD
Arformoterol—Body temperature increased—Vemurafenib—skin cancer	0.000729	0.00199	CcSEcCtD
Arformoterol—Pharyngitis—Dactinomycin—skin cancer	0.000728	0.00199	CcSEcCtD
Arformoterol—Urinary tract infection—Temozolomide—skin cancer	0.000719	0.00197	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000717	0.00196	CcSEcCtD
Arformoterol—Insomnia—Imiquimod—skin cancer	0.000712	0.00195	CcSEcCtD
Arformoterol—Upper respiratory tract infection—Fluorouracil—skin cancer	0.00071	0.00194	CcSEcCtD
Arformoterol—Cardiac failure congestive—Docetaxel—skin cancer	0.000704	0.00192	CcSEcCtD
Arformoterol—Dyspnoea—Imiquimod—skin cancer	0.000702	0.00192	CcSEcCtD
Arformoterol—Somnolence—Imiquimod—skin cancer	0.0007	0.00191	CcSEcCtD
Arformoterol—Sinusitis—Temozolomide—skin cancer	0.000694	0.0019	CcSEcCtD
Arformoterol—Dyspepsia—Imiquimod—skin cancer	0.000693	0.00189	CcSEcCtD
Arformoterol—Hypersensitivity—Vemurafenib—skin cancer	0.00068	0.00186	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Imiquimod—skin cancer	0.000679	0.00186	CcSEcCtD
Arformoterol—Fatigue—Imiquimod—skin cancer	0.000678	0.00186	CcSEcCtD
Arformoterol—Atrial fibrillation—Docetaxel—skin cancer	0.000673	0.00184	CcSEcCtD
Arformoterol—Pain—Imiquimod—skin cancer	0.000673	0.00184	CcSEcCtD
Arformoterol—Acute coronary syndrome—Fluorouracil—skin cancer	0.000672	0.00184	CcSEcCtD
Arformoterol—Myocardial infarction—Fluorouracil—skin cancer	0.000668	0.00183	CcSEcCtD
Arformoterol—Conjunctivitis—Fluorouracil—skin cancer	0.000662	0.00181	CcSEcCtD
Arformoterol—Urinary tract infection—Fluorouracil—skin cancer	0.000662	0.00181	CcSEcCtD
Arformoterol—Asthenia—Vemurafenib—skin cancer	0.000662	0.00181	CcSEcCtD
Arformoterol—Pharyngitis—Temozolomide—skin cancer	0.000659	0.0018	CcSEcCtD
Arformoterol—Urinary tract disorder—Temozolomide—skin cancer	0.000656	0.00179	CcSEcCtD
Arformoterol—Oedema peripheral—Temozolomide—skin cancer	0.000654	0.00179	CcSEcCtD
Arformoterol—Pruritus—Vemurafenib—skin cancer	0.000653	0.00179	CcSEcCtD
Arformoterol—Connective tissue disorder—Temozolomide—skin cancer	0.000652	0.00178	CcSEcCtD
Arformoterol—Urethral disorder—Temozolomide—skin cancer	0.000651	0.00178	CcSEcCtD
Arformoterol—Feeling abnormal—Imiquimod—skin cancer	0.000648	0.00177	CcSEcCtD
Arformoterol—Gastrointestinal pain—Imiquimod—skin cancer	0.000643	0.00176	CcSEcCtD
Arformoterol—Visual impairment—Temozolomide—skin cancer	0.00064	0.00175	CcSEcCtD
Arformoterol—Sinusitis—Fluorouracil—skin cancer	0.000639	0.00175	CcSEcCtD
Arformoterol—Ill-defined disorder—Bleomycin—skin cancer	0.000636	0.00174	CcSEcCtD
Arformoterol—Diarrhoea—Vemurafenib—skin cancer	0.000631	0.00173	CcSEcCtD
Arformoterol—Urticaria—Imiquimod—skin cancer	0.000625	0.00171	CcSEcCtD
Arformoterol—Abdominal pain—Imiquimod—skin cancer	0.000622	0.0017	CcSEcCtD
Arformoterol—Body temperature increased—Imiquimod—skin cancer	0.000622	0.0017	CcSEcCtD
Arformoterol—Malaise—Bleomycin—skin cancer	0.000618	0.00169	CcSEcCtD
Arformoterol—Cardiac disorder—Temozolomide—skin cancer	0.000616	0.00168	CcSEcCtD
Arformoterol—Rhinitis—Fluorouracil—skin cancer	0.000613	0.00168	CcSEcCtD
Arformoterol—Dizziness—Vemurafenib—skin cancer	0.00061	0.00167	CcSEcCtD
Arformoterol—Pharyngitis—Fluorouracil—skin cancer	0.000607	0.00166	CcSEcCtD
Arformoterol—Immune system disorder—Temozolomide—skin cancer	0.0006	0.00164	CcSEcCtD
Arformoterol—Mediastinal disorder—Temozolomide—skin cancer	0.000598	0.00164	CcSEcCtD
Arformoterol—Cough—Bleomycin—skin cancer	0.000598	0.00163	CcSEcCtD
Arformoterol—Dehydration—Docetaxel—skin cancer	0.000593	0.00162	CcSEcCtD
Arformoterol—Ill-defined disorder—Dactinomycin—skin cancer	0.000593	0.00162	CcSEcCtD
Arformoterol—Vomiting—Vemurafenib—skin cancer	0.000587	0.0016	CcSEcCtD
Arformoterol—Dry skin—Docetaxel—skin cancer	0.000585	0.0016	CcSEcCtD
Arformoterol—Chest pain—Bleomycin—skin cancer	0.000583	0.00159	CcSEcCtD
Arformoterol—Myalgia—Bleomycin—skin cancer	0.000583	0.00159	CcSEcCtD
Arformoterol—Rash—Vemurafenib—skin cancer	0.000582	0.00159	CcSEcCtD
Arformoterol—Mental disorder—Temozolomide—skin cancer	0.000582	0.00159	CcSEcCtD
Arformoterol—Dermatitis—Vemurafenib—skin cancer	0.000581	0.00159	CcSEcCtD
Arformoterol—Hypersensitivity—Imiquimod—skin cancer	0.00058	0.00159	CcSEcCtD
Arformoterol—Headache—Vemurafenib—skin cancer	0.000578	0.00158	CcSEcCtD
Arformoterol—Malnutrition—Temozolomide—skin cancer	0.000578	0.00158	CcSEcCtD
Arformoterol—Discomfort—Bleomycin—skin cancer	0.000576	0.00158	CcSEcCtD
Arformoterol—Malaise—Dactinomycin—skin cancer	0.000576	0.00158	CcSEcCtD
Arformoterol—Cramp muscle—Docetaxel—skin cancer	0.000575	0.00157	CcSEcCtD
Arformoterol—Nasopharyngitis—Docetaxel—skin cancer	0.000571	0.00156	CcSEcCtD
Arformoterol—Dysgeusia—Temozolomide—skin cancer	0.000566	0.00155	CcSEcCtD
Arformoterol—Asthenia—Imiquimod—skin cancer	0.000565	0.00154	CcSEcCtD
Arformoterol—Oedema—Bleomycin—skin cancer	0.000559	0.00153	CcSEcCtD
Arformoterol—Anaphylactic shock—Bleomycin—skin cancer	0.000559	0.00153	CcSEcCtD
Arformoterol—Back pain—Temozolomide—skin cancer	0.000559	0.00153	CcSEcCtD
Arformoterol—Pruritus—Imiquimod—skin cancer	0.000557	0.00152	CcSEcCtD
Arformoterol—Infection—Bleomycin—skin cancer	0.000555	0.00152	CcSEcCtD
Arformoterol—Nausea—Vemurafenib—skin cancer	0.000548	0.0015	CcSEcCtD
Arformoterol—Arrhythmia—Fluorouracil—skin cancer	0.000546	0.00149	CcSEcCtD
Arformoterol—Myalgia—Dactinomycin—skin cancer	0.000544	0.00149	CcSEcCtD
Arformoterol—Bronchospasm—Docetaxel—skin cancer	0.000542	0.00148	CcSEcCtD
Arformoterol—Tremor—Temozolomide—skin cancer	0.000541	0.00148	CcSEcCtD
Arformoterol—Diarrhoea—Imiquimod—skin cancer	0.000538	0.00147	CcSEcCtD
Arformoterol—Discomfort—Dactinomycin—skin cancer	0.000537	0.00147	CcSEcCtD
Arformoterol—Angina pectoris—Docetaxel—skin cancer	0.000537	0.00147	CcSEcCtD
Arformoterol—Ill-defined disorder—Temozolomide—skin cancer	0.000536	0.00147	CcSEcCtD
Arformoterol—Agitation—Temozolomide—skin cancer	0.000531	0.00145	CcSEcCtD
Arformoterol—Angioedema—Temozolomide—skin cancer	0.000528	0.00144	CcSEcCtD
Arformoterol—Hypotension—Bleomycin—skin cancer	0.000522	0.00143	CcSEcCtD
Arformoterol—Oedema—Dactinomycin—skin cancer	0.000521	0.00143	CcSEcCtD
Arformoterol—Malaise—Temozolomide—skin cancer	0.000521	0.00142	CcSEcCtD
Arformoterol—Dizziness—Imiquimod—skin cancer	0.00052	0.00142	CcSEcCtD
Arformoterol—Infection—Dactinomycin—skin cancer	0.000518	0.00142	CcSEcCtD
Arformoterol—Palpitations—Temozolomide—skin cancer	0.000511	0.0014	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000509	0.00139	CcSEcCtD
Arformoterol—Cough—Temozolomide—skin cancer	0.000504	0.00138	CcSEcCtD
Arformoterol—Vomiting—Imiquimod—skin cancer	0.0005	0.00137	CcSEcCtD
Arformoterol—Hypertension—Temozolomide—skin cancer	0.000499	0.00136	CcSEcCtD
Arformoterol—Dyspnoea—Bleomycin—skin cancer	0.000498	0.00136	CcSEcCtD
Arformoterol—Rash—Imiquimod—skin cancer	0.000496	0.00136	CcSEcCtD
Arformoterol—Dermatitis—Imiquimod—skin cancer	0.000496	0.00136	CcSEcCtD
Arformoterol—Headache—Imiquimod—skin cancer	0.000493	0.00135	CcSEcCtD
Arformoterol—Myalgia—Temozolomide—skin cancer	0.000492	0.00135	CcSEcCtD
Arformoterol—Arthralgia—Temozolomide—skin cancer	0.000492	0.00135	CcSEcCtD
Arformoterol—Anxiety—Temozolomide—skin cancer	0.00049	0.00134	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000489	0.00134	CcSEcCtD
Arformoterol—Discomfort—Temozolomide—skin cancer	0.000486	0.00133	CcSEcCtD
Arformoterol—Acute coronary syndrome—Docetaxel—skin cancer	0.000485	0.00133	CcSEcCtD
Arformoterol—Myocardial infarction—Docetaxel—skin cancer	0.000482	0.00132	CcSEcCtD
Arformoterol—Dry mouth—Temozolomide—skin cancer	0.000481	0.00132	CcSEcCtD
Arformoterol—Pain—Bleomycin—skin cancer	0.000478	0.00131	CcSEcCtD
Arformoterol—Conjunctivitis—Docetaxel—skin cancer	0.000478	0.00131	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000475	0.0013	CcSEcCtD
Arformoterol—Anaphylactic shock—Temozolomide—skin cancer	0.000472	0.00129	CcSEcCtD
Arformoterol—Oedema—Temozolomide—skin cancer	0.000472	0.00129	CcSEcCtD
Arformoterol—Infection—Temozolomide—skin cancer	0.000468	0.00128	CcSEcCtD
Arformoterol—Nausea—Imiquimod—skin cancer	0.000467	0.00128	CcSEcCtD
Arformoterol—Nervous system disorder—Temozolomide—skin cancer	0.000462	0.00126	CcSEcCtD
Arformoterol—Feeling abnormal—Bleomycin—skin cancer	0.000461	0.00126	CcSEcCtD
Arformoterol—Skin disorder—Temozolomide—skin cancer	0.000458	0.00125	CcSEcCtD
Arformoterol—Chest pain—Fluorouracil—skin cancer	0.000453	0.00124	CcSEcCtD
Arformoterol—Myalgia—Fluorouracil—skin cancer	0.000453	0.00124	CcSEcCtD
Arformoterol—Fatigue—Dactinomycin—skin cancer	0.00045	0.00123	CcSEcCtD
Arformoterol—Discomfort—Fluorouracil—skin cancer	0.000448	0.00122	CcSEcCtD
Arformoterol—Pain—Dactinomycin—skin cancer	0.000446	0.00122	CcSEcCtD
Arformoterol—Urticaria—Bleomycin—skin cancer	0.000444	0.00121	CcSEcCtD
Arformoterol—Rhinitis—Docetaxel—skin cancer	0.000443	0.00121	CcSEcCtD
Arformoterol—Body temperature increased—Bleomycin—skin cancer	0.000442	0.00121	CcSEcCtD
Arformoterol—Pharyngitis—Docetaxel—skin cancer	0.000438	0.0012	CcSEcCtD
Arformoterol—Urinary tract disorder—Docetaxel—skin cancer	0.000436	0.00119	CcSEcCtD
Arformoterol—Oedema peripheral—Docetaxel—skin cancer	0.000435	0.00119	CcSEcCtD
Arformoterol—Oedema—Fluorouracil—skin cancer	0.000435	0.00119	CcSEcCtD
Arformoterol—Anaphylactic shock—Fluorouracil—skin cancer	0.000435	0.00119	CcSEcCtD
Arformoterol—Connective tissue disorder—Docetaxel—skin cancer	0.000434	0.00119	CcSEcCtD
Arformoterol—Urethral disorder—Docetaxel—skin cancer	0.000433	0.00118	CcSEcCtD
Arformoterol—Infection—Fluorouracil—skin cancer	0.000432	0.00118	CcSEcCtD
Arformoterol—Feeling abnormal—Dactinomycin—skin cancer	0.00043	0.00117	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00043	0.00117	CcSEcCtD
Arformoterol—Insomnia—Temozolomide—skin cancer	0.000427	0.00117	CcSEcCtD
Arformoterol—Gastrointestinal pain—Dactinomycin—skin cancer	0.000426	0.00117	CcSEcCtD
Arformoterol—Nervous system disorder—Fluorouracil—skin cancer	0.000426	0.00117	CcSEcCtD
Arformoterol—Visual impairment—Docetaxel—skin cancer	0.000425	0.00116	CcSEcCtD
Arformoterol—Tachycardia—Fluorouracil—skin cancer	0.000424	0.00116	CcSEcCtD
Arformoterol—Dyspnoea—Temozolomide—skin cancer	0.00042	0.00115	CcSEcCtD
Arformoterol—Somnolence—Temozolomide—skin cancer	0.000419	0.00115	CcSEcCtD
Arformoterol—Dyspepsia—Temozolomide—skin cancer	0.000415	0.00114	CcSEcCtD
Arformoterol—Abdominal pain—Dactinomycin—skin cancer	0.000412	0.00113	CcSEcCtD
Arformoterol—Body temperature increased—Dactinomycin—skin cancer	0.000412	0.00113	CcSEcCtD
Arformoterol—Hypersensitivity—Bleomycin—skin cancer	0.000412	0.00113	CcSEcCtD
Arformoterol—Cardiac disorder—Docetaxel—skin cancer	0.00041	0.00112	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Temozolomide—skin cancer	0.000407	0.00111	CcSEcCtD
Arformoterol—Fatigue—Temozolomide—skin cancer	0.000407	0.00111	CcSEcCtD
Arformoterol—Hypotension—Fluorouracil—skin cancer	0.000406	0.00111	CcSEcCtD
Arformoterol—Pain—Temozolomide—skin cancer	0.000403	0.0011	CcSEcCtD
Arformoterol—Constipation—Temozolomide—skin cancer	0.000403	0.0011	CcSEcCtD
Arformoterol—Asthenia—Bleomycin—skin cancer	0.000401	0.0011	CcSEcCtD
Arformoterol—Immune system disorder—Docetaxel—skin cancer	0.000399	0.00109	CcSEcCtD
Arformoterol—Mediastinal disorder—Docetaxel—skin cancer	0.000398	0.00109	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000396	0.00108	CcSEcCtD
Arformoterol—Pruritus—Bleomycin—skin cancer	0.000396	0.00108	CcSEcCtD
Arformoterol—Arrhythmia—Docetaxel—skin cancer	0.000394	0.00108	CcSEcCtD
Arformoterol—Insomnia—Fluorouracil—skin cancer	0.000393	0.00107	CcSEcCtD
Arformoterol—Feeling abnormal—Temozolomide—skin cancer	0.000389	0.00106	CcSEcCtD
Arformoterol—Dyspnoea—Fluorouracil—skin cancer	0.000387	0.00106	CcSEcCtD
Arformoterol—Mental disorder—Docetaxel—skin cancer	0.000387	0.00106	CcSEcCtD
Arformoterol—Somnolence—Fluorouracil—skin cancer	0.000386	0.00106	CcSEcCtD
Arformoterol—Gastrointestinal pain—Temozolomide—skin cancer	0.000386	0.00105	CcSEcCtD
Arformoterol—Malnutrition—Docetaxel—skin cancer	0.000384	0.00105	CcSEcCtD
Arformoterol—Hypersensitivity—Dactinomycin—skin cancer	0.000384	0.00105	CcSEcCtD
Arformoterol—Dyspepsia—Fluorouracil—skin cancer	0.000382	0.00105	CcSEcCtD
Arformoterol—Dysgeusia—Docetaxel—skin cancer	0.000376	0.00103	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000375	0.00103	CcSEcCtD
Arformoterol—Urticaria—Temozolomide—skin cancer	0.000375	0.00102	CcSEcCtD
Arformoterol—Asthenia—Dactinomycin—skin cancer	0.000374	0.00102	CcSEcCtD
Arformoterol—Abdominal pain—Temozolomide—skin cancer	0.000373	0.00102	CcSEcCtD
Arformoterol—Body temperature increased—Temozolomide—skin cancer	0.000373	0.00102	CcSEcCtD
Arformoterol—Back pain—Docetaxel—skin cancer	0.000372	0.00102	CcSEcCtD
Arformoterol—Pain—Fluorouracil—skin cancer	0.000372	0.00102	CcSEcCtD
Arformoterol—Muscle spasms—Docetaxel—skin cancer	0.000369	0.00101	CcSEcCtD
Arformoterol—Feeling abnormal—Fluorouracil—skin cancer	0.000358	0.000979	CcSEcCtD
Arformoterol—Diarrhoea—Dactinomycin—skin cancer	0.000357	0.000975	CcSEcCtD
Arformoterol—Vomiting—Bleomycin—skin cancer	0.000355	0.000972	CcSEcCtD
Arformoterol—Rash—Bleomycin—skin cancer	0.000352	0.000964	CcSEcCtD
Arformoterol—Dermatitis—Bleomycin—skin cancer	0.000352	0.000963	CcSEcCtD
Arformoterol—Hypersensitivity—Temozolomide—skin cancer	0.000347	0.00095	CcSEcCtD
Arformoterol—Urticaria—Fluorouracil—skin cancer	0.000345	0.000944	CcSEcCtD
Arformoterol—Body temperature increased—Fluorouracil—skin cancer	0.000343	0.000939	CcSEcCtD
Arformoterol—Palpitations—Docetaxel—skin cancer	0.00034	0.000929	CcSEcCtD
Arformoterol—Asthenia—Temozolomide—skin cancer	0.000338	0.000925	CcSEcCtD
Arformoterol—Cough—Docetaxel—skin cancer	0.000335	0.000917	CcSEcCtD
Arformoterol—Pruritus—Temozolomide—skin cancer	0.000334	0.000912	CcSEcCtD
Arformoterol—Nausea—Bleomycin—skin cancer	0.000332	0.000908	CcSEcCtD
Arformoterol—Hypertension—Docetaxel—skin cancer	0.000332	0.000907	CcSEcCtD
Arformoterol—Vomiting—Dactinomycin—skin cancer	0.000332	0.000906	CcSEcCtD
Arformoterol—Rash—Dactinomycin—skin cancer	0.000329	0.000899	CcSEcCtD
Arformoterol—Myalgia—Docetaxel—skin cancer	0.000327	0.000895	CcSEcCtD
Arformoterol—Arthralgia—Docetaxel—skin cancer	0.000327	0.000895	CcSEcCtD
Arformoterol—Chest pain—Docetaxel—skin cancer	0.000327	0.000895	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000325	0.000888	CcSEcCtD
Arformoterol—Diarrhoea—Temozolomide—skin cancer	0.000323	0.000882	CcSEcCtD
Arformoterol—Hypersensitivity—Fluorouracil—skin cancer	0.00032	0.000875	CcSEcCtD
Arformoterol—Dry mouth—Docetaxel—skin cancer	0.00032	0.000875	CcSEcCtD
Arformoterol—Oedema—Docetaxel—skin cancer	0.000314	0.000858	CcSEcCtD
Arformoterol—Anaphylactic shock—Docetaxel—skin cancer	0.000314	0.000858	CcSEcCtD
Arformoterol—Dizziness—Temozolomide—skin cancer	0.000312	0.000853	CcSEcCtD
Arformoterol—Infection—Docetaxel—skin cancer	0.000312	0.000852	CcSEcCtD
Arformoterol—Nausea—Dactinomycin—skin cancer	0.00031	0.000847	CcSEcCtD
Arformoterol—Nervous system disorder—Docetaxel—skin cancer	0.000308	0.000841	CcSEcCtD
Arformoterol—Pruritus—Fluorouracil—skin cancer	0.000307	0.000841	CcSEcCtD
Arformoterol—Tachycardia—Docetaxel—skin cancer	0.000306	0.000837	CcSEcCtD
Arformoterol—Skin disorder—Docetaxel—skin cancer	0.000305	0.000833	CcSEcCtD
Arformoterol—Vomiting—Temozolomide—skin cancer	0.0003	0.00082	CcSEcCtD
Arformoterol—Rash—Temozolomide—skin cancer	0.000297	0.000813	CcSEcCtD
Arformoterol—Diarrhoea—Fluorouracil—skin cancer	0.000297	0.000813	CcSEcCtD
Arformoterol—Dermatitis—Temozolomide—skin cancer	0.000297	0.000812	CcSEcCtD
Arformoterol—Headache—Temozolomide—skin cancer	0.000295	0.000808	CcSEcCtD
Arformoterol—Hypotension—Docetaxel—skin cancer	0.000293	0.000801	CcSEcCtD
Arformoterol—Dizziness—Fluorouracil—skin cancer	0.000287	0.000786	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000286	0.000781	CcSEcCtD
Arformoterol—Insomnia—Docetaxel—skin cancer	0.000284	0.000776	CcSEcCtD
Arformoterol—Nausea—Temozolomide—skin cancer	0.00028	0.000766	CcSEcCtD
Arformoterol—Dyspnoea—Docetaxel—skin cancer	0.00028	0.000765	CcSEcCtD
Arformoterol—Somnolence—Docetaxel—skin cancer	0.000279	0.000762	CcSEcCtD
Arformoterol—Vomiting—Fluorouracil—skin cancer	0.000276	0.000755	CcSEcCtD
Arformoterol—Dyspepsia—Docetaxel—skin cancer	0.000276	0.000755	CcSEcCtD
Arformoterol—Rash—Fluorouracil—skin cancer	0.000274	0.000749	CcSEcCtD
Arformoterol—Dermatitis—Fluorouracil—skin cancer	0.000274	0.000748	CcSEcCtD
Arformoterol—Headache—Fluorouracil—skin cancer	0.000272	0.000744	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Docetaxel—skin cancer	0.000271	0.00074	CcSEcCtD
Arformoterol—Fatigue—Docetaxel—skin cancer	0.00027	0.000739	CcSEcCtD
Arformoterol—Pain—Docetaxel—skin cancer	0.000268	0.000733	CcSEcCtD
Arformoterol—Constipation—Docetaxel—skin cancer	0.000268	0.000733	CcSEcCtD
Arformoterol—Feeling abnormal—Docetaxel—skin cancer	0.000258	0.000707	CcSEcCtD
Arformoterol—Nausea—Fluorouracil—skin cancer	0.000258	0.000706	CcSEcCtD
Arformoterol—Gastrointestinal pain—Docetaxel—skin cancer	0.000256	0.000701	CcSEcCtD
Arformoterol—Abdominal pain—Docetaxel—skin cancer	0.000248	0.000678	CcSEcCtD
Arformoterol—Body temperature increased—Docetaxel—skin cancer	0.000248	0.000678	CcSEcCtD
Arformoterol—Hypersensitivity—Docetaxel—skin cancer	0.000231	0.000632	CcSEcCtD
Arformoterol—Asthenia—Docetaxel—skin cancer	0.000225	0.000615	CcSEcCtD
Arformoterol—Pruritus—Docetaxel—skin cancer	0.000222	0.000607	CcSEcCtD
Arformoterol—Diarrhoea—Docetaxel—skin cancer	0.000215	0.000587	CcSEcCtD
Arformoterol—Dizziness—Docetaxel—skin cancer	0.000207	0.000567	CcSEcCtD
Arformoterol—Vomiting—Docetaxel—skin cancer	0.000199	0.000545	CcSEcCtD
Arformoterol—Rash—Docetaxel—skin cancer	0.000198	0.000541	CcSEcCtD
Arformoterol—Dermatitis—Docetaxel—skin cancer	0.000198	0.00054	CcSEcCtD
Arformoterol—Headache—Docetaxel—skin cancer	0.000196	0.000537	CcSEcCtD
Arformoterol—Nausea—Docetaxel—skin cancer	0.000186	0.000509	CcSEcCtD
